HIV Preexposure Prophylaxis Clinical Trial
Official title:
A Multicenter, Observational Cohort to Study the Characteristics of Individuals Asking for Pre-exposure Prophylaxis (PrEP) and the Incidence of HIV and Other Sexually Transmitted Infections: 'The SwissPrEPared Study'
Nested within the SwissPrEPared Program, the "SwissPrEPared Study" - a large, multicentric, nation-wide cohort study - aims to longitudinally follow individuals asking for PrEP prescription over a period of 3 years.
The main aims of the study will be: 1. To obtain epidemiological data on individuals asking for PrEP in Switzerland. We are particularly interested in: - Determining the extent of PrEP use in Switzerland; - Assessing and monitoring the occurrence of sexually transmitted infections (STIs) in this particular population. 2. To assess sexual health and sexual well-being in individuals asking for PrEP using a questionnaire specifically designed for the SwissPrEPared program. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT04754139 -
A Promotion and Implementation Project of HIV Pre-Exposure Prophylaxis Among High Risk Population
|
N/A | |
| Completed |
NCT02074891 -
Sustainable Healthcenter Implementation PrEP Pilot Study
|
||
| Recruiting |
NCT04424524 -
Streamlining the Efficiency of PrEP Implementation
|
||
| Completed |
NCT04652700 -
Oral Islatravir (MK-8591) Once-Monthly as Preexposure Prophylaxis (PrEP) in Men and Transgender Women Who Are at High Risk for HIV-1 Infection (MK-8591-024)
|
Phase 3 |